← Leaderboards
Joseph F Pierre
University Of Chicago
$3,797,332
Attributed
$8,521,754
Total exposure
5
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.2M · FY2015–25$2.5M$1.9M$1.3M$625K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,521,754 · 5
By mechanism
U01$4,079,710 · 1
R01$3,946,928 · 2
R21$440,922 · 1
F32$54,194 · 1
Top collaborators
- Liza Makowski Hayes10 shared
- Ankush Gosain3 shared
- Eugene B Chang2 shared
- Brian M Peters2 shared
- Katherine Loree Cook1 shared
- Jeffrey C Rathmell1 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Eugene B Chang$58,954,761
- Vanessa Anne Leone$1,182,469
- Sonia Kupfer$5,816,081
Others in their field
Top investigators on “In Vitro”
- David Heimbrook · Leidos Biomedical Research, Inc.$553,787,942
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,441,779
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- Lynn Briscoe · Leidos Biomedical Research, Inc.$94,686,873
- Dennis R. Burton · Scripps Research Institute$79,204,175
Research focus
In VitroMicrobialImmuneResponseMicrobiomeMediatingMicrobeInnovationIncidenceMalignant Breast NeoplasmBreast Cancer CellBody Weight DecreasedIntestinesMalignant NeoplasmsBariatric SurgeryMetabolicObesityBreast Cancer ModelCellsBile AcidsImmunotherapyAffectLinkSignal Transduction
Grant awards (16)
Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk.$1,046,868
U01 · FY2025 · CA
Exploring the role, regulation, and antimicrobial function of Paneth cell peptides PYY and NPY in maintaining gut microbial commensalism and innate immune defense$686,064
R01 · FY2025 · DK
Role of microbially-derived metabolites in anti-tumor immunity in breast cancer$488,057
R01 · FY2025 · CA
Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk.$1,003,836
U01 · FY2024 · CA
Exploring the role, regulation, and antimicrobial function of Paneth cell peptides PYY and NPY in maintaining gut microbial commensalism and innate immune defense$719,417
R01 · FY2024 · DK
Role of microbial-modulated bile acid receptor signaling in breast cancer$380,449
R01 · FY2024 · CA
Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk.$978,693
U01 · FY2023 · CA
Role of microbial-modulated bile acid receptor signaling in breast cancer$419,927
R01 · FY2023 · CA
Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk.$1,050,313
U01 · FY2022 · CA
Role of microbial-modulated bile acid receptor signaling in breast cancer$431,028
R01 · FY2022 · CA
Modeling Host-Fungal Interactions in Hirschsprung-Associated Enterocolitis$199,814
R21 · FY2022 · AI
Modeling Host-Fungal Interactions in Hirschsprung-Associated Enterocolitis$48,816
R21 · FY2022 · AI
Role of microbial-modulated bile acid receptor signaling in breast cancer$404,685
R01 · FY2021 · CA
Modeling Host-Fungal Interactions in Hirschsprung-Associated Enterocolitis$192,292
R21 · FY2021 · AI
Role of microbial-modulated bile acid receptor signaling in breast cancer$417,301
R01 · FY2020 · CA
Novel role and function of Paneth cell PYY in anti-fungal innate immunity$54,194
F32 · FY2015 · DK · contact PI